Prominent child psychiatrist suspends relationship with drug makers
Boston Globe, December 31, 2008
Dr. Joseph Biederman, a prominent child psychiatrist whose relationship with drug makers is under scrutiny, will temporarily suspend his ties to the pharmaceutical industry under an agreement reached with his employer, Massachusetts General Hospital. A hospital spokeswoman said that Biederman, who specializes in diagnosing and treating bipolar disorder, has withdrawn from running several industry-funded clinical trials, and that another physician will assume oversight of the research.
- Sharp HealthCare Leaves Pioneer ACO Program
- Acute Kidney Injury Gets New Focus
- CNO Leads $1M Charge for New Scrubs, Uniforms
- Interventional Radiology No Longer a Sub-Specialty
- NFP Hospitals' Revenue Growth at 'All-Time Low'
- Half of All Primary Care, Internal Medicine Jobs Unfilled in 2013
- MA an Insurance Proving Ground for Providers
- PCI: Concerns Mount About Appropriateness
- Targeting Self-Insured Populations
- mHealth Tackles Readmissions